Arke Formulations Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 25 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
- Revenue Growth 7.42%
- Profit Growth 26.88%
- Ebitda 596.11%
- Net Worth 6.78%
- Total Assets -12.37%
About Arke Formulations
Arke Formulations Private Limited (AFPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 January 2000 and has a history of 25 years and one month. Its registered office is in Rajkot, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹5.00 M.
Kaushalbhai Dhuleshia and Jigneshkumar Kantesaria serve as directors at the Company.
Company Details
-
Location
Rajkot, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ2000PTC037141
-
Company No.
037141
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jan 2000
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Arke Formulations Private Limited offer?
Arke Formulations Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Herbal Oil, Ayurvedic & Herbal Health Supplement, Herbal Juice, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Guggul, Ayurvedic Medicine, Ayurvedic Churna and Goli, Ayurvedic Pain Relief Oil.
Who are the key members and board of directors at Arke Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaushalbhai Dhuleshia
|
Director | 29-Dec-2001 | Current |
|
Jigneshkumar Kantesaria
|
Director | 25-Feb-2006 | Current |
Financial Performance of Arke Formulations.
Arke Formulations Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.42% increase. The company also saw a substantial improvement in profitability, with a 26.88% increase in profit. The company's net worth moved up by a moderate rise of 6.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arke Formulations?
In 2021, Arke Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 May 2021 | Others | ₹5.00 M | Open |
How Many Employees Work at Arke Formulations?
Unlock and access historical data on people associated with Arke Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arke Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arke Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
